Medicine and Dentistry
Wart Virus
77%
Oropharynx Squamous Cell Carcinoma
75%
Radiation Therapy
73%
Neoplasm
56%
Oropharynx Carcinoma
43%
Overall Survival
40%
P16
39%
Neck
36%
Head and Neck Squamous Cell Carcinoma
27%
Recurrent Disease
25%
Diseases
25%
Head and Neck Cancer
24%
Intensity Modulated Radiation Therapy
23%
Hazard Ratio
21%
Squamous Cell Carcinoma
20%
Cisplatin
19%
Disease Free Survival
17%
Disease Specific Survival
15%
Malignant Neoplasm
14%
Oncology
13%
Distant Metastasis
12%
Cetuximab
11%
Induction Chemotherapy
11%
Biological Marker
10%
Contouring
10%
Adjuvant Therapy
10%
Chemoradiotherapy
10%
microRNA
10%
Phase II Trials
8%
Lymph Node
8%
Oropharynx
8%
Progression Free Survival
8%
Cancer
8%
Neck Dissection
8%
Merkel Cell Carcinoma
8%
Paclitaxel
8%
Computer Assisted Tomography
7%
Treatment Planning
7%
Metastatic Carcinoma
7%
Oral Cavity
7%
Tissue Microarray
7%
Primary Tumor
6%
In Situ Hybridization
6%
Quality of Life
6%
Contralateral
6%
Positron Emission Tomography-Computed Tomography
6%
Cancer of Unknown Primary Origin
6%
Immunohistochemistry
6%
Clinical Trial
5%
Cancer Therapy
5%
Keyphrases
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
High-risk Human Papillomavirus (HR-HPV)
77%
Radiation Therapy
47%
Overall Survival
41%
Head-and-neck Cancer
36%
Tumor
35%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
34%
Head-and-neck
29%
Locally Advanced
24%
P16-positive
22%
Hazard Ratio
22%
Cisplatin
20%
Confidence Interval
20%
Radiotherapy
20%
Disease-specific Survival
18%
Disease-free Survival
17%
Nasopharyngeal Carcinoma
16%
Phase II Trial
16%
Distant Metastasis
14%
Intensity-modulated Radiation Therapy
14%
Cetuximab
13%
Induction Chemotherapy
13%
Adjuvant Therapy
12%
Neck Dissection
11%
Squamous Cell Carcinoma of Head
11%
Surgically Treated
11%
Nab-paclitaxel
10%
Recurrent Disease
9%
Progression-free Survival
9%
Tumor Delineation
9%
Intraoperative Radiation Therapy
9%
Radiation Therapy Oncology Group
8%
Transoral Surgery
8%
NRG Oncology
8%
Positron Emission Tomography-computed Tomography (PET-CT)
8%
Gene Signature
8%
Merkel Cell Carcinoma
8%
Computed Tomography
7%
Non-small Cell Lung Cancer (NSCLC)
7%
Concurrent Radiation
7%
Cancer Outcomes
7%
Tissue Microarray
7%
MicroRNA
7%
Intensity-modulated Radiotherapy
7%
Locoregional Recurrence
7%
Squamous Cell Carcinoma (SqCC)
6%
Patient Outcomes
6%
Oncological Outcomes
6%
Treatment Outcome
6%
Lung
6%